title: Approval summary for bortezomib for injection in the treatment of multiple myeloma.
authors.affiliation: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, USA. bross@cber.fda.gov
authors.forename: Peter F
authors.initials: PF
authors.lastname: Bross
authors.forename: Robert
authors.initials: R
authors.lastname: Kane
authors.forename: Ann T
authors.initials: AT
authors.lastname: Farrell
authors.forename: Sophia
authors.initials: S
authors.lastname: Abraham
authors.forename: Kimberly
authors.initials: K
authors.lastname: Benson
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Brower
authors.forename: Sean
authors.initials: S
authors.lastname: Bradley
authors.forename: Jogarao V
authors.initials: JV
authors.lastname: Gobburu
authors.forename: Anwar
authors.initials: A
authors.lastname: Goheer
authors.forename: Shwu-Luan
authors.initials: SL
authors.lastname: Lee
authors.forename: John
authors.initials: J
authors.lastname: Leighton
authors.forename: Cheng Yi
authors.initials: CY
authors.lastname: Liang
authors.forename: Richard T
authors.initials: RT
authors.lastname: Lostritto
authors.forename: William D
authors.initials: WD
authors.lastname: McGuinn
authors.forename: David E
authors.initials: DE
authors.lastname: Morse
authors.forename: Atiqur
authors.initials: A
authors.lastname: Rahman
authors.forename: Lilliam A
authors.initials: LA
authors.lastname: Rosario
authors.forename: S Leigh
authors.initials: SL
authors.lastname: Verbois
authors.forename: Grant
authors.initials: G
authors.lastname: Williams
authors.forename: Yong-Cheng
authors.initials: YC
authors.lastname: Wang
authors.forename: Richard
authors.initials: R
authors.lastname: Pazdur
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008956:Models, Chemical; D009101:Multiple Myeloma / Q000188:drug therapy*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D011719:Pyrazines / Q000627:therapeutic use*; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D046988:Proteasome Endopeptidase Complex